What That Means for Genetic Risk

Rumours and speculation have been proliferating rapidly that President Trump’s physical and mental health are in decline. While Trump frequently boasts about his MRI results, this has not deterred the questions on his cognitive abilities and mental aptitude to hold office. However, Trump has bragged about his results stating he’s “aced” numerous cognitive tests and even challenged other oppositional political figures such as Rep. Alexandria Ocasio-Cortez and Jasmine Crockett to take the same test.  The Montreal Cognitive Assessment (MoCA), which is likely the test Trump took, tests for early signs of dementia and any cognitive decline. The fact that Donald Trump’s father, Fred Trump, suffered from dementia raises the question whether Trump might have inherited the condition. While genetic risk does exist, the relationship between genes and disease is complex. Yes, family history increases susceptibility but lifestyle factors play a more significant role in increasing risk of dementia. Fred Trump, the patriarch of the Trump family and successful real estate mogul received a diagnosis of Alzheimer’s disease in 1991 at age 86. He lived with Alzheimer’s for 8 years before his passing in 1999 at age 93.

Understanding Alzheimer’s Disease Heredity

According to research published in the Cold Spring Harbor Laboratory Press, family history is the second strongest risk factor for Alzheimer’s disease after advanced age. Genetic factors play a role in at least 80% of all Alzheimer’s cases, as indicated by twin and family studies conducted. However, the inheritance pattern shows important distinctions that determine actual risk levels. Individuals with a parent or sibling living with Alzheimer’s face higher odds of developing the disease themselves. People with 1 first-degree relative with Alzheimer’s show a 73% increased risk (1.73 times more likely). Those with 2 first-degree relatives face nearly quadruple the risk (3.98 times). The numbers climb dramatically with 3 first-degree relatives (2.48 times) and 4 or more (14.77 times). However, modifiable factors such as bad sleeping habits, hypertension, or diabetes can greatly increase dementia risk. 

Risk Genes Versus Deterministic Genes

The Alzheimer’s Association further explains that one can either inherit risk genes or deterministic genes. Risk genes increase the likelihood of developing disease but guarantee nothing, whereas deterministic genes virtually ensure you develop Alzheimer’s and are linked with early-onset of the disease. Risk genes make up the majority of genetic Alzheimer’s risk factors. More than 100 risk genes are suspected of increasing susceptibility for late-onset Alzheimer’s disease. These genes influence disease probability rather than inevitability. The APOE gene stands as the most significant risk gene identified. It comes in three variants: APOE2, APOE3, and APOE4.

Deterministic genes are extremely rare, accounting for less than 1% of all Alzheimer’s cases. These genes include APP, PSEN1, and PSEN2. They cause early-onset familial Alzheimer’s disease, typically before age 65. A person needs only one copy of these variants to develop disease. If a parent carries one of these mutations, each child has a 50% chance of inheriting it.

Genetic Testing Considerations

Most physicians would advise against routine genetic testing for late-onset Alzheimer’s risk genes. Their reasoning behind this centres on limited clinical utility and poor predictive value. APOE testing cannot definitively predict who will develop disease. Current medical guidelines advise against APOE testing in asymptomatic individuals. Testing for early-onset deterministic genes should only occur in specific situations which include symptomatic individuals with early-onset Alzheimer’s in families with dementia history. Testing may also apply when a relative carries a known mutation. Recent developments are changing this landscape. New amyloid-lowering drugs approved for Alzheimer’s treatment make APOE genotype clinically relevant. Clinical trials show strong associations between APOE genotype and both drug safety and efficacy. APOE4 carriers face higher risks of certain treatment side effects.

Genetic testing for treatment decisions requires careful counseling. Pre-test education helps patients understand test implications. Patients and families need to grasp what results mean for treatment options and monitoring requirements. This counseling process mirrors protocols developed for Huntington’s disease testing.

Lifestyle Factors That Modify Alzheimer’s Risk

Research continually shows that lifestyle habits and modifications can drastically reduce Alzheimer’s risk, even in genetically susceptible individuals. A comprehensive UK Biobank study examined 196,383 adults over age 60. Researchers calculated genetic risk scores based on approximately 30 Alzheimer’s-associated genes. They also assessed lifestyle factors including diet, physical activity, smoking status, and alcohol consumption. Their findings demonstrated that dementia rates were 32% lower in people with high genetic risk who maintained healthy lifestyles. This protection held regardless of their baseline genetic risk level. People with high genetic risk and poor health habits showed about 3 times higher dementia likelihood versus those with low genetic risk and good habits.

Another study examining 5 low-risk lifestyle factors found powerful protective effects. Participants adopting 4 or 5 healthy behaviors showed 60% lower Alzheimer’s risk compared to those following none or one. Each additional healthy lifestyle factor decreased risk by 22%. John Haaga of the U.S. National Institute on Aging offered encouraging perspective. “No one can guarantee you’ll escape this awful disease, but you can tip the odds in your favor with clean living,” he noted. 

Mediterranean Diet and Brain Health

According to research, the Mediterranean diet demonstrates positive outcomes against cognitive decline and Alzheimer’s disease. This dietary style centres around vegetables, fruits, whole grains, fish, olive oil, nuts, and legumes. It limits red meat, processed foods, and foods high in sugar and saturated fat. A 2025 meta-analysis examined studies published between 2000 and 2024. The analysis found substantial protective effects against cognitive decline and Alzheimer’s. For cognitive impairment, the hazard ratio was 0.82, indicating 18% risk reduction. For dementia, the hazard ratio reached 0.89, showing 11% protection. For Alzheimer’s disease specifically, the hazard ratio was 0.70, demonstrating 30% risk reduction.

Research suggests adherence to the Mediterranean diet correlates with 11-30% reduction in age-related cognitive disorder risk. A study of 581 participants who donated brains for dementia research revealed that those with Mediterranean diets were associated with fewer Alzheimer’s signs in brain tissue. This effect primarily reflected lower amyloid plaque levels.

Recent research from Mass General Brigham and Harvard shows diet can offset genetic risk. The protective effect proved strongest in high-risk groups carrying two APOE4 copies. Study co-author Yuxi Liu explained the significance. “These findings suggest that dietary strategies could help reduce the risk of cognitive decline and stave off dementia by broadly influencing key metabolic pathways,” Liu stated. APOE4 carriers may benefit from specific dietary changes. Their brains transport omega-3 fatty acids less efficiently so they may need higher DHA intake to function normally. Limiting refined carbohydrates appears particularly important for this group. Several weekly servings of DHA-rich fatty fish support brain health in APOE4 carriers.

Physical Activity and Cognitive Protection

Physical exercise ranks among the most powerful Alzheimer’s prevention strategies. Exercise activates multiple protective mechanisms simultaneously. It increases blood flow to the brain, promotes neurogenesis, enhances synaptic plasticity, and facilitates amyloid clearance Aerobic physical exercise triggers release of neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF). These molecules facilitate neurogenesis and synaptogenesis, improving memory and cognitive function. One study showed that one year of moderate aerobic exercise increased hippocampal volume by 2%. This exercise training is associated with increased plasma BDNF concentrations.

An American study of 1,740 subjects over age 65 found compelling results. Dementia incidence reached 13.0 per 1,000 person-years for participants exercising 3 or more times weekly. Those exercising fewer than three times weekly showed 19.7 per 1,000 person-years incidence. Exercise sessions included at least 15 minutes of activities like walking, cycling, swimming, or strength training. Higher physical activity intensity may provide additional benefits. A longitudinal study of 143,325 subjects tracked outcomes over 1 year. Those practicing high-intensity activities like cycling, aerobics, or tennis showed 40% lower risk than sedentary individuals. Even low-intensity activities like walking or dancing offered some protection.

Recent research using objective activity measurements provides precise dose-response data. In individuals with elevated baseline amyloid, even low activity levels (3,001-5,000 steps daily) substantially slowed tau accumulation and cognitive decline. Moderate activity (5,001-7,500 steps daily) provided further protection. Active individuals (7,500+ steps daily) showed similar benefits. APOE4 carriers may gain greater cognitive benefits from exercise than non-carriers. Studies suggest they respond particularly well to higher-intensity or more frequent workouts. Higher omega-3 index combined with APOE4 genotype associates with less small-vessel brain disease. As researcher Melo van Lent noted, “If there is a modifiable risk factor that can outweigh genetic predisposition, that’s a big gain”.

Sleep Quality and Dementia Risk

Sleep quality plays a crucial role in Alzheimer’s prevention and disease progression. During sleep, the brain eliminates beta-amyloid plaques, one of the primary Alzheimer’s markers. Sleep deprivation significantly raises interstitial fluid amyloid levels, exacerbating cognitive decline. Research estimates that 45% of individuals with cognitive impairment experience sleep disturbances before cognitive symptoms appear. This temporal relationship suggests sleep problems may contribute to disease development rather than merely resulting from it.

Studies associate several sleep disorders with increased cognitive impairment risk. Obstructive sleep apnea, insomnia, and disrupted sleep-wake cycles all correlate with higher Alzheimer’s likelihood. Circadian rhythm disruptions lead to increased amyloid accumulation, inflammation, and oxidative stress. Sleep duration shows clear relationships with amyloid burden. Individuals sleeping more than seven hours show the least amyloid burden. Those sleeping less than six hours show the most. Participants sleeping between six and seven hours demonstrate intermediate burden levels.

Deep sleep appears especially essential for brain clearance. Slow delta waves occurring during non-rapid eye movement (NREM) sleep link to increased glymphatic inflow and amyloid clearance. Research shows participants with more fragmented sleep and less deep sleep were more likely to show protein increases related to Alzheimer’s. An additional hour of nighttime sleep led to considerable reduction in both global and regional amyloid accumulation. In contrast, daytime sleep showed no correlation with global amyloid levels. These results suggest adequate nighttime sleep offers significant protection against early amyloid accumulation. Sleep quality recommendations for brain health include seven to eight hours nightly. Treating sleep disorders like sleep apnea may help prevent cognitive impairment by improving sleep quality. Sleep medication intake among those with sleeping problems may offer cognitive protection benefits.

Cardiovascular Health and Brain Protection

Managing cardiovascular health represents a crucial dementia prevention strategy. Keeping blood pressure, cholesterol, and blood sugar in check reduces strain on the brain. The principle “what benefits your heart will also benefit your brain” holds strong scientific support. Hypertension stands as a significant modifiable Alzheimer’s risk factor. A global meta-analysis examined data from six large studies tracking over 31,000 adults over age 55. Treating high blood pressure reduced dementia risk by 12% and Alzheimer’s risk by 16%. The blood pressure medication type did not affect protective benefits.

Cholesterol management also influences Alzheimer’s risk, though relationships prove complex. Abnormal cholesterol levels as early as age 35 may associate with later-life Alzheimer’s risk. Lower HDL cholesterol and higher triglyceride levels in early adulthood contribute to future disease risk. High blood glucose levels in middle adulthood similarly increase risk. Diabetes substantially elevates Alzheimer’s likelihood. Among people with diabetes, Alzheimer’s risk increases by approximately 65% compared to non-diabetic individuals. One community study found 35% of people with Alzheimer’s had frank diabetes. An additional 46% showed glucose intolerance. Together, up to 80% of Alzheimer’s patients may have diabetes or glucose intolerance.

Building Cognitive Reserve Through Mental Stimulation

Cognitive reserve refers to the brain’s ability to maintain cognitive function despite neurodegeneration from pathology or normal aging. This reserve allows the brain to adjust and compensate for challenges through neuroplasticity. Higher cognitive reserve associates with delayed symptom onset in Alzheimer’s disease. Studies show individuals with elevated reserve maintain relatively normal cognitive functioning despite significant brain structural reductions. This protection occurs through compensatory increases in functional activation.

Education serves as a well-established cognitive reserve proxy. Analysis shows education moderates the impact of pathological load on cognitive performance. Higher reserve scores attenuate Alzheimer’s pathology effects on cognitive decline over time. Years of education positively associate with reserve scores that protect against decline.

Read More: Trump Moves to Reshape Cannabis Law: Which States Could See Legalization Next?